Skip to main content
. 2021 Mar 26;9(3):e27767. doi: 10.2196/27767

Table 1.

Clinical decision support system accuracy by cohort.

Cohort Overall eligibility (%) Metastatic breast cancer (%) Neoadjuvant setting (%) HER2 status (%) Hormone receptor status (%)
Group 1 90.6 95.4 100 88.9 93.5
Group 2 87.6 90.4 87.2 93 88.6